@article{ajmcr2021928,
author={{Costanzo, Louis and Pendkar, Chetana and Shafi, Amara and Gorga, Joseph},
title={Insulin Resistance One Mechanism Two Presentations: Olanzapine Induced DKA and Hypertriglyceridemia},
journal={American Journal of Medical Case Reports},
volume={9},
number={2},
pages={131--133},
year={2021},
url={http://pubs.sciepub.com/ajmcr/9/2/8},
issn={2374-216X},
abstract={Patients taking antipsychotic medications have a well-established increased risk of developing metabolic syndrome. These medications interfere with an intracellular signaling pathway leading to insulin resistance; that of which can lead to dangerous complications including diabetic ketoacidosis (DKA) and severe hypertriglyceridemia. We report a case of a 21-year-old man who developed DKA and severe hypertriglyceridemia secondary to the use of olanzapine used for the management of schizophrenia.},
doi={10.12691/ajmcr-9-2-8}
publisher={Science and Education Publishing}
}